Organoids for Virus Research - An innovative training-ETN programme
Objective
OrganoVIR includes leading partners in virology and organoid technology covering 7 academic institutes, 3 life science companies, 1 organoid technology private company, 2 non-profit organisations, a national public health institute and a business school originating from 8 countries.
The aim is to introduce and establish human organoids as superior models for viral pathogenesis studies and antiviral testing, thus replacing animal models and reducing animal use. OrganoVIR provides a full package ETN programme for ESRs to learn the science of innovative 3D culture systems for virus research as well as financial, commercial, ethical, communicative, policy and dissemination aspects for optimal valorization. The projects are intensified by significant secondments at commercial, governmental and non-profit partner institutes.
OrganoVIR provides:
- High-ranked scientific and technical training in an interdisciplinary, intersectoral and international top research project
- Training in transferrable managerial skills, including a pre-MBA
- Implementation of innovative organoid technology for viral pathogenesis studies and antiviral development
- Innovation in organoid technology by co-culture design and high throughput screening.
OrganoVIR combines frontier research with an innovative training programme in a complementary network, certifying high impact scientists.
Programme(s)
H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers
Funding Scheme
MSCA-ITN-ETN - European Training Networks
Coordinator
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Address
Meibergdreef 9
1105az Amsterdam
Netherlands
Activity type
Higher or Secondary Education Establishments
EU Contribution
€ 531 239,76
Participants (9)
Sort alphabetically
Sort by EU Contribution
Expand all
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU Contribution
€ 768 960
UNIWERSYTET JAGIELLONSKI
Poland
EU Contribution
€ 454 957,20
DANMARKS TEKNISKE UNIVERSITET
Denmark
EU Contribution
€ 297 522
STEMCELL TECHNOLOGIES UK LTD
United Kingdom
EU Contribution
€ 303 172,56
UNIVERSITEIT UTRECHT
Netherlands
EU Contribution
€ 265 619,88
CHARLES RIVER NEDERLAND BV
Netherlands
EU Contribution
€ 265 619,88
UNIVERSITE DE GENEVE
Switzerland
EU Contribution
€ 281 276,64
UNIVERSITEIT VAN AMSTERDAM
Netherlands
EU Contribution
€ 265 619,88
UNIVERSITE CLERMONT AUVERGNE
France
EU Contribution
€ 549 604,08
Partners (5)
Sort alphabetically
Expand all
Organome LLC
STICHTING PROEFDIERVRIJ* DUTCH SOCIETY FOR THE REPLACEMENT OF ANIMAL TESTING
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU
EPITHELIX SARL
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW
Project information
OrganoVIR
Grant agreement ID: 812673
Status
Ongoing project
-
Start date
1 January 2019
-
End date
31 December 2022
Funded under:
H2020-EU.1.3.1.
-
Overall budget:
€ 3 983 591,88
-
EU contribution
€ 3 983 591,88
Project information
OrganoVIR
Grant agreement ID: 812673
Status
Ongoing project
-
Start date
1 January 2019
-
End date
31 December 2022
Funded under:
H2020-EU.1.3.1.
-
Overall budget:
€ 3 983 591,88
-
EU contribution
€ 3 983 591,88
Deliverables
Deliverables not available
Publications
Publications not available
Project information
OrganoVIR
Grant agreement ID: 812673
Status
Ongoing project
-
Start date
1 January 2019
-
End date
31 December 2022
Funded under:
H2020-EU.1.3.1.
-
Overall budget:
€ 3 983 591,88
-
EU contribution
€ 3 983 591,88
Project information
OrganoVIR
Grant agreement ID: 812673
Status
Ongoing project
-
Start date
1 January 2019
-
End date
31 December 2022
Funded under:
H2020-EU.1.3.1.
-
Overall budget:
€ 3 983 591,88
-
EU contribution
€ 3 983 591,88
